PPT-Natalizumab ( Approved, Investigational)
Author : Aquamarine | Published Date : 2022-08-03
DB ID DB09026 Category Immunosuppressive agents Half life 11 4 days Volume of distribution 57 19 L Multiple Sclerosis MS Patients 52 28 L Crohns
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Natalizumab ( Approved, Investigational)" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Natalizumab ( Approved, Investigational): Transcript
Download Document
Here is the link to download the presentation.
"Natalizumab ( Approved, Investigational)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
